1. Home
  2. CNTN vs ARQQ Comparison

CNTN vs ARQQ Comparison

Compare CNTN & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$2.84

Market Cap

185.3M

Sector

Health Care

ML Signal

N/A

Logo Arqit Quantum Inc.

ARQQ

Arqit Quantum Inc.

HOLD

Current Price

$23.29

Market Cap

211.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNTN
ARQQ
Founded
2017
2017
Country
United States
United Kingdom
Employees
12
91
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
185.3M
211.3M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
CNTN
ARQQ
Price
$2.84
$23.29
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$60.00
AVG Volume (30 Days)
1.3M
1.4M
Earning Date
05-13-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$381.13
Revenue Next Year
N/A
$212.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.14
$11.52
52 Week High
$5.27
$62.00

Technical Indicators

Market Signals
Indicator
CNTN
ARQQ
Relative Strength Index (RSI) 46.09 53.96
Support Level $2.14 $21.80
Resistance Level $3.80 $30.28
Average True Range (ATR) 0.31 4.36
MACD -0.01 0.40
Stochastic Oscillator 19.83 56.83

Price Performance

Historical Comparison
CNTN
ARQQ

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

About ARQQ Arqit Quantum Inc.

Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment, that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.

Share on Social Networks: